Difference between revisions of "Developer Summit 2008"
(→Organizing Team: less spam ?)
m (25 revision(s))
Revision as of 09:54, 13 May 2008
The 2008 SELinux Developer Summit is to be held in Ottawa on the 22nd of July, as an OLS mini-summit.
This will be an open event, although, to attend, you must be registered to attend OLS.
The SELinux Developer Summit will be a one day summit intended to provide a forum for focused technical discussion regarding current and future development plans for SELinux and related Flask/TE projects. The intended audience will consist of current SELinux developers, system/security administrators, distribution organizers/packagers, and power users. The format will be a set of moderated discussion panels with brief presentations.
This year's presentations and discussions will be divided into two categories: usability and infrastructure. General usability of SELinux systems has consistently improved but, with increasingly wide adoption of SELinux, also become ever more important. Usability topics we plan on addressing include policy development, administration of SELinux enabled systems, and desktop integration including X11. The core infrastructure topics include embedded systems, label translation, userspace object managers, network filesystems, and labeled networking.
- Event announcement - 02 April 2008
- CFP start - 04 April 2008
- CFP end - 18 April 2008
- Notify presenters - 25 April 2008
- Publish schedule - 02 May 2008
Call for Participation
The schedule is now published:
Please discuss general issues relating to the summit on the SELinux Mailing List.
The 2008 organizing team is as follows:
- Serge Hallyn <email@example.com> (IBM)
- Paul Moore <firstname.lastname@example.org> (HP)
- James Morris <email@example.com> (Red Hat)
- Karl MacMillan <firstname.lastname@example.org> (Tresys)
- Stephen Smalley <email@example.com> (NSA)
To contact the team as a group, send email to: selinux-summit-team AT namei.org.
- 2006 Developer Summit Baltimore, MD.
- 2007 Developer Summit Baltimore, MD.